Three Seattle scientists who have been studying the coronavirus have been selected among hundreds for national biomedical funding that offers millions of dollars toward their research, positioning them for possible scientific breakthroughs down the road. Trevor Bedford, Frederick Matsen IV and David Veesler are among 33 researchers recognized this year by the Howard Hughes Medical Institute (HHMI), the largest private biomedical research…
Read More

Meet the 2021-2022 ISCRM Fellows

The ISCRM Fellows program began in 2017, the year the Washington State Legislature first included funding for ISCRM in the state budget. In a critical show of support for stem cell research, the legislature appropriated $2.25 million for core staff and technologies, innovation pilot awards for faculty, and a trainee fellowship program to help the UW fulfill its mission, increase…
Read More
Bayer announced the 2020 recipients of the annual Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a U.S.-based research grant program created to support clinical research in pulmonary hypertension (PH), with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The seven recipients will receive a combined total of $1 million in grants over a two-year period, making…
Read More
A backpack-size kidney-dialysis device, conceived and being developed at the University of Washington Center for Dialysis Innovation (CDI), is one of six winners of a $650,000 prize in an international competition to create components and systems for artificial kidneys. The awards were announced today by KidneyX, a public-private partnership of the American Society of Nephrology and U.S. Department of Health and Human…
Read More
How variations in the DNA sequences in the human genome affect how cells’ function and, ultimately, how these variants influence human health and disease, are critical questions that will be addressed by a new research consortium. Scientists at the University of Washington School of Medicine will be part of this major, multi-institution effort. The National Institutes of Health has awarded $16 million to UW Medicine…
Read More

W.M. Keck Foundation Funds Liver Research In Stevens Lab

In the United States today, approximately one in ten people suffers from liver disease and one in 2,500 children are born with the condition. Liver disease can arise from a number of causes, including genetics, diet, and complications from other diseases and can lead to liver failure, cancer, or death. Liver transplants offer some hope and relief. However, waitlists are…
Read More
Diagnostics startup ID Genomics will accelerate its development of a quick test for variants of the COVID-19 virus with a new grant from the U.S. National Institutes of Health. The Seattle-based company announced the $300,000 small business grant Tuesday for the dipstick-based test, currently dubbed CovNET. ID Genomics is also eligible for a follow-on grant of up to $3 million.…
Read More
Research to halt the harms caused by Alzheimer’s disease has yielded promising insights and strategies to help people remain cognitively healthy. Now, a new infusion of money to a landmark study tracking older adults will allow researchers to bring about more effective treatments and ways to prevent the disease. The National Institute of Aging, part of the National Institutes of…
Read More
Two postdoctoral researchers at Fred Hutchinson Cancer Research Center are among the 17 early career scientists announced this week as fellows of the Damon Runyon Cancer Research Foundation. Drs. Edie Crosse and Ching-Ho Chang and their fellow honorees across the U.S. will receive four years of funding for their “creative and high-risk projects dedicated to the search for cancer causes,…
Read More
Lumen Bioscience, a clinical-stage biopharmaceutical company developing products to treat and prevent highly prevalent diseases, today announced the results of a research collaboration with Google that applied machine learning (ML) to significantly advance the scalability of spirulina-based biologic drugs. The research, led by Caitlin Gamble, Lumen and Drew Bryant at Google Accelerated Science, was funded in part by the Bill…
Read More